格隆汇2月11日｜TD Cowen将默克公司的评级从“买入”下调至“持有”，目标价从121美元下调至100美元，原因是该公司的业绩指引疲软，而且HPV疫苗在中国的发货情况尚不明确。(格隆汇)

海量资讯、精准解读，尽在新浪财经APP

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.